HOF Capital Completes €1 Billion Acquisition of Porsche’s Stakes in Bugatti Rimac and Rimac Group
9.9.2026 18:00:00 CEST | Business Wire | Press Release
HOF Capital today announced the completion of its acquisition of Porsche’s equity interests in Bugatti Rimac and Rimac Group through an HOF-led consortium. The transaction, first announced in April 2026, closed following the satisfaction of all conditions, including regulatory clearances. Porsche’s combined interests were valued at approximately €1 billion.
HOF Capital originated and led the transaction, assembling a consortium of institutional investors from the United States and Europe. Following completion of the transaction, HOF holds a 23.5% stake and becomes the largest shareholder in Rimac Group, which holds the 55% controlling interest in Bugatti Rimac. HOF and its consortium also acquired Porsche’s direct 45% interest in Bugatti Rimac.
As part of the investment, HOF Capital holds three supervisory board seats across Rimac Group and Bugatti Rimac. Hisham Elhaddad, Co-Founder and Managing Partner of HOF Capital, has joined the Supervisory Boards of both Bugatti Rimac and Rimac Group. Josh Klaczek, Partner at HOF Capital, joins the Rimac Group Supervisory Board as the firm’s second representative.
Hisham Elhaddad, Co-Founder and Managing Partner of HOF Capital commented: “This transaction reflects exactly the kind of partnership HOF was built for – backing durable, category-defining businesses across industries. Bugatti’s position at the apex of personal luxury and bespoke craftsmanship is especially compelling as we enter an era defined by abundance. We are excited to be partnering with a world-class leader in Mate Rimac and his exceptional team to enhance the value of this iconic brand. For HOF, this deal marks a natural extension of our venture roots into leading complex transactions across the capital structure.”
Mate Rimac, CEO of Bugatti Rimac: “This is an important step for Bugatti Rimac and the entire Rimac Group. I am delighted that HOF Capital and its consortium are becoming our partners in the next phase of our Group's development, and I look forward to working together to realize the full potential of our companies. We have made strong progress across all companies in the Group, and I believe this partnership gives additional momentum to our continued growth.”
ABOUT BUGATTI
Founded in 1909 by Ettore Bugatti in Molsheim, France, Bugatti is one of the world’s most exclusive automotive marques — synonymous with a singular blend of artistry, craftsmanship, and engineering excellence. Since 2021, the brand has operated as part of Bugatti Rimac, led by Chief Executive Officer Mate Rimac. Bugatti’s latest flagship, the Tourbillon, marks the beginning of a new chapter for the marque. Bugatti remains headquartered at its historic home in Molsheim, with additional operations in Zagreb, Croatia.
ABOUT RIMAC GROUP
Rimac Group is the majority shareholder of Bugatti Rimac, the sole owner of Rimac Technology and Rimac Energy, and a significant minority investor in Verne. Rimac Group companies employ over 2,000 employees, develop and produce Bugatti and Rimac branded hypercars as well as battery systems, powertrain systems, electronics, and stationary storage systems. Rimac’s headquarters is based on the outskirts of Zagreb, Croatia, with additional locations across Europe.
ABOUT HOF CAPITAL
HOF Capital is a New York-based investment firm with approximately $15 billion in AUM. The firm invests globally across venture capital and growth equity, partnering with companies from first check through IPO. HOF has backed several of today’s most consequential companies early on, including Anthropic and SpaceX, and invests thematically across AI, frontier technologies, critical infrastructure, and iconic brands. Its investor base spans Fortune 500 enterprises, financial institutions, and industry-leading founders worldwide. For more information, visit hofcapital.com.
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security or investment product, and shall not form the basis of or be relied on in connection with any investment decision.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260909929325/en/
Contacts
MEDIA CONTACT
Prosek Partners
pro-HofCapital@prosek.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Convatec Survey Challenges Assumptions About Leakage in Ostomy Care6.10.2026 09:00:00 CEST | Press Release
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routine care. For many people, leakage is not only a clinical or product issue; it can shape whether they feel able to travel, exercise, socialise or take part fully in everyday life. More than half of respondents said they avoid such activities due to worry about their ostomy. The results of the survey, which included more than 1,800 people living with an ostomy and over 400 healthcare professionals, point to a significant opportunity to improve outcomes through greater focus on peristomal skin health, the specific area of s
Oulu2026 Boosts Tourism as Björk, Art and Technology Lead the European Capital of Culture Year’s Finale6.10.2026 09:00:00 CEST | Press Release
The Oulu2026 European Capital of Culture programme has attracted visitors to northern Finland and contributed to strong tourism growth. According to Visit Oulu statistics, Oulu recorded nearly 475,000 registered overnight stays between January and August 2026, an increase of 12 per cent year on year. International overnight stays rose by 21 per cent to more than 96,600, while domestic overnight stays increased by 9 per cent. The trend continued in August, when international overnight stays grew by almost 29 per cent year on year. Hundreds of events combining art, technology, science, music, theatre and sport continue throughout the final months of 2026. “The programme’s diversity is clearest in the final months. There is something for culture enthusiasts and families alike, with experiences that cannot be found anywhere else. If ever there was a time to visit Oulu, it is now,” says Samu Forsblom, Programme Director of Oulu2026. A major highlight is the Lumo Art & Tech Festival, taking
Ant International and HSBC Expand Real-Time Treasury Management Services to the Middle East6.10.2026 08:30:00 CEST | Press Release
Ant International today announced an expanded collaboration with HSBC to enhance real-time treasury management services in the Middle East. By leveraging HSBC’s global Tokenised Deposit Service (TDS), Ant International aims to improve the efficiency of its treasury operations across the region. As part of the collaboration, Ant International has successfully completed pilot transactions across two payment corridors connecting the United Arab Emirates and Hong Kong: Intra-UAE dirham transfers: Real-time, dirham-denominated tokenised deposit transactions within the UAE. Cross-border US dollar payments initiated from the UAE: US dollar-denominated tokenised deposit transfers between the UAE and international markets, including Hong Kong and Singapore. These transactions were initiated via WhaleRTP – Ant International’s proprietary, blockchain-based real-time treasury management platform – and executed in real-time through HSBC’s TDS. Ant International and HSBC jointly designed the transac
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing6.10.2026 08:00:00 CEST | Press Release
RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to accelerate the digital transformation of its manufacturing operations in Scotland. The funding, supported by a Scottish Enterprise R&D grant of up to £7.25 million, forms part of RoslinCT's ambitious digital expansion plan, a multi-year initiative designed to enhance the company's integrated digital and AI capabilities and further strengthen Scotland's position as a global hub for advanced cell and gene therapy manufacturing. The programme will enable the development of a digitally integrated manufacturing environment, improving operational efficiency, data connectivity and manufacturing excellence across RoslinCT's operations. By creating a more connected and data-driven manufacturing environment, RoslinCT will be better positioned to support clients throughout the product lifecycle, helping b
30 Years of Restylane ® : Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation6.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, celebrates 30 years since Restylane was launched in Europe as the first hyaluronic acid (HA) injectable.1 With HA closest to the skin’s own, Restylane is designed to deliver personalized, natural-looking outcomes that meet diverse patient needs across key areas of the face, décolletage, and hands.8,10,12,21-31 With three decades of innovation across technology, packaging, and treatment areas, Restylane remains at the forefront of innovation, evolving from its original NASHA®, technology into a comprehensive portfolio spanning three distinct technologies: NASHA HD™, NASHA®, and OBT™.1,8,21,22 Together, these technologies offer solutions ranging from firmer gels that provide contouring and structural support, to soft, flexible formulations that smooth facial lines and wrinkles for a more youthful look.8,12,21-31 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202610
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom